Cargando…
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancer
BACKGROUND: Invasive lobular carcinoma (ILC) as a disease entity distinct from invasive ductal carcinoma (IDC) has merited focused studies of the genomic landscape, but those to date are largely limited to the assessment of early-stage cancers. Given that genomic alterations develop as acquired resi...
Autores principales: | Sokol, E S, Feng, Y X, Jin, D X, Basudan, A, Lee, A V, Atkinson, J M, Chen, J, Stephens, P J, Frampton, G M, Gupta, P B, Ross, J S, Chung, J H, Oesterreich, S, Ali, S M, Hartmaier, R J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6336006/ https://www.ncbi.nlm.nih.gov/pubmed/30423024 http://dx.doi.org/10.1093/annonc/mdy497 |
Ejemplares similares
-
FGFR4 overexpression and hotspot mutations in metastatic ER+ breast cancer are enriched in the lobular subtype
por: Levine, Kevin M., et al.
Publicado: (2019) -
Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer
por: Du, Tian, et al.
Publicado: (2018) -
WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines
por: Sikora, Matthew J., et al.
Publicado: (2016) -
Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer
por: Hartmaier, R J, et al.
Publicado: (2018) -
Molecular drivers of lobular carcinoma in situ
por: Logan, Greg J., et al.
Publicado: (2015)